Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of Panax ginseng
Authors:
- 20 March 2020
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 34 (13) , e8788
Abstract
Rationale: Panax ginseng C.A. Meyer (PG), which contains polysaccharides and ginsenosides as the major bioactive components, has been used to promote health and treat diseases for thousands of years in China. Total ginsenosides were extracted from a decoction of Panax ginseng (GD), which included both ginsenosides and polysaccharides, and dissolved in water to obtain a total ginsenosides aqueous solution (TGAS). To study their absorption and metabolism, the pharmacokinetics (PK) and metabolites of ginsenosides in vivo were investigated after the administration of GD and TGAS. Methods: Rat and mice plasma samples were collected after the administration of GD and TGAS. Ultra‐performance liquid chromatography coupled with time‐of‐flight mass spectrometry was used with the UNIFI platform to identify metabolites in the plasma sample. The pharmacokinetic parameters were calculated using a noncompartmental method in the Drug and Statistics software package. Results: Thirty ginsenoside metabolites were identified in mice plasma, of which only seven were found in the rat plasma after the administration of GD. The PK of ginsenosides Rb 1 , Rc, and Rd were also determined after the oral administration of GD and TGAS and showed significant differences in the pharmacokinetic parameters. Conclusions: There was no difference in the biotransformation pathways after the oral administration of GD and TGAS, indicating that there was no influence of polysaccharides on the biotransformation of ginsenosides in vivo . However, the pharmacokinetic parameters were different after the administration of GD and TGAS, possibly because of the polysaccharides in GD. This study should be of significance in exploring the basis of PG bioactivities and lays the foundation for the further development of new drugs using PG.Keywords
Funding Information
- National Natural Science Foundation of China (31700293)
- National Basic Research Program of China (2017YFC1702100)
This publication has 41 references indexed in Scilit:
- Updating chemical profiling of red ginseng via the elucidation of two geometric isomers of ginsenosides Rg9 and Rg10Food Chemistry, 2013
- Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanismJournal of Ginseng Research, 2013
- Ginseng saponins and the treatment of osteoporosis: mini literature reviewJournal of Ginseng Research, 2013
- Identification of metabolites of honokiol in rat urine using 13C stable isotope labeling and liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometryJournal of Chromatography A, 2013
- Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser157phosphorylation on thrombin-induced platelet aggregationJournal of Ginseng Research, 2013
- Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical ApplicationsJournal of Ginseng Research, 2012
- Trends in Ginseng Research in 2010Journal of Ginseng Research, 2011
- Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2008
- Immune System Effects of Echinacea, Ginseng, and Astragalus: A ReviewIntegrative Cancer Therapies, 2003
- Studies on Dammarane-Type Saponins in the Flower-Buds ofPanax ginsengC.A. MeyerJournal of Asian Natural Products Research, 1998